Compile Data Set for Download or QSAR
Report error Found 19 Enz. Inhib. hit(s) with all data for entry = 50010868
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50098643(1-((E)-1-Cyclooct-1-enyl)methyl-4-[(2,7-dichloro-9...)
Affinity DataIC50: 0.580nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50098643(1-((E)-1-Cyclooct-1-enyl)methyl-4-[(2,7-dichloro-9...)
Affinity DataIC50: 0.900nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099482(2-(6-Amino-benzothiazol-2-ylsulfanyl)-N-[1-(3,4-di...)
Affinity DataIC50: 2.30nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099479(N-[1-(3,4-Dichloro-benzyl)-piperidin-4-yl]-2-(6-et...)
Affinity DataIC50: 20nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099480(2-(Benzothiazol-2-ylsulfanyl)-N-[1-(3,4-dichloro-b...)
Affinity DataIC50: 32nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099483(2-{[1-(3,4-Dichloro-benzyl)-piperidin-4-ylcarbamoy...)
Affinity DataIC50: 48nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099476(2-(Benzothiazol-2-ylsulfanyl)-N-[1-(4-chloro-benzy...)
Affinity DataIC50: 79nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099476(2-(Benzothiazol-2-ylsulfanyl)-N-[1-(4-chloro-benzy...)
Affinity DataIC50: 260nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099477(2-(Benzothiazol-2-ylsulfanyl)-N-[1-(3-chloro-benzy...)
Affinity DataIC50: 280nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099480(2-(Benzothiazol-2-ylsulfanyl)-N-[1-(3,4-dichloro-b...)
Affinity DataIC50: 450nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099481(2-(Benzothiazol-2-ylsulfanyl)-N-(1-benzyl-piperidi...)
Affinity DataIC50: 750nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099478(2-(Benzothiazol-2-ylsulfanyl)-N-(1-cyclohexylmethy...)
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099475(2-(Benzothiazol-2-ylsulfanyl)-N-(1-benzyl-piperidi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099482(2-(6-Amino-benzothiazol-2-ylsulfanyl)-N-[1-(3,4-di...)
Affinity DataIC50: 1.90E+3nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099479(N-[1-(3,4-Dichloro-benzyl)-piperidin-4-yl]-2-(6-et...)
Affinity DataIC50: 3.60E+3nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099475(2-(Benzothiazol-2-ylsulfanyl)-N-(1-benzyl-piperidi...)
Affinity DataIC50: 4.20E+3nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099481(2-(Benzothiazol-2-ylsulfanyl)-N-(1-benzyl-piperidi...)
Affinity DataIC50: 7.10E+3nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099477(2-(Benzothiazol-2-ylsulfanyl)-N-[1-(3-chloro-benzy...)
Affinity DataIC50: 1.00E+4nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC-C chemokine receptor type 1(Human)
Banyu Tsukuba Research Institute

Curated by ChEMBL
LigandPNGBDBM50099483(2-{[1-(3,4-Dichloro-benzyl)-piperidin-4-ylcarbamoy...)
Affinity DataIC50: 1.00E+4nMAssay Description:Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed